Extracted from this filing and checked against the source text.
Material Agreements
SEC 8-K Item 1.01/1.02
confidence 0.95
ClearPoint Neuro, Inc. amended Consent to Note Purchase Agreement with CALW SA LLC (as Purchaser Agent) and TPC Investments III LP (affiliate of Oberland Capital Management LLC) valued at Consent to allow internal reorganization of Swedish subsidiary and qualify IRRAS AB as an Immaterial (effective 2025-12-29).
- Action
- amendment
- Agreement
- notes offering
- Counterparty
- CALW SA LLC (as Purchaser Agent) and TPC Investments III LP (affiliate of Oberland Capital Management LLC)
- Value
- Consent to allow internal reorganization of Swedish subsidiary and qualify IRRAS AB as an Immaterial
- Effective
- 2025-12-29
Exact text from the filing
On December 29, 2025, the Company entered into a Consent (the “Consent”) with Purchaser Agent and the 2025 Investor providing for the Company to undertake the following actions no later than January 15, 2026: (i) an internal reorganization involving the Company’s Swedish subsidiary, IRRAS AB, including the transfer of all equity interests of IRRAS USA, Inc. owned by IRRAS AB to the Company or its direct, wholly owned U.S. subsidiary in exchange for a subordinated intercompany note, and (ii) other further actions so as to allow IRRAS AB to qualify as an “Immaterial Foreign Subsidiary” under the terms of the Note Purchase Agreement.
View on SEC.gov